利凡诺中晚期妊娠引产的临床分析

CLINICAL ANALYSIS OF TERMINATION OF MID AND LATE PREGNANCY WITH RIVANOL

应用利凡诺１００ｍｇ羊膜腔内注射引产７５５例。结果：一次成功７４５例，占９８．６８％；术前用抗生素组并发症少，并且与未用抗生素进行对照，有显著差异（Ｐ＜０．０５）；提示：当宫缩较弱时，及时适量加用催产素静滴；常规行清宫术；术前始给予抗生素等对减少并发症提高成功率具有重要意义。另外，瘢痕子宫也不完全是引产的禁忌症。

ivanol(100mg)were given to 775 cases into theiramniotic cavities for termination ofmid and late pregnancy, It was successful for 745 cases(98^68%)in the first time.Therewas a striking contrast(P<0.05 ) between the antibacterial group and non-antibacterialgroup. For the antibacterial group,few complications and no serious complications tookplace. The paper showed that it is important for decreasing the complication and increasingthe successful rate to use oxytocin when uterotonic is weak.to curet routinely afterthe deliv-ery and to give the antibacterial before the operation.In addition,we suggest this methodcould be used on the scared uterine selectively.